EUVIMEDEUVIMED entdecken
Crossref

Biomineralized Multienzyme‐Mimicking 2D Nanoplatform Achieves Efficient Redox‐Governed Reversal of Tumor Multidrug Resistance

Da-Gui Zhang iD, Yang Zhang iD, Hui-Ya Hong, Xiao-Chang Lu, Wei-Guang Xiong iD, Yi-Ting Qiu, Qin-Xi Xu, Ze-Teng Wang, Lin-Fei Chen, Ai-Zheng Chen iD, Shi-Bin Wang, Biao-Qi Chen iD

Advanced Healthcare Materials · 2026-11 · 15 (42)

DOI: 10.1002/adhm.71617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 20.08.2026. Verfasst von Da-Gui Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Biochemical Technology & Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Drug Resistance, Multiple, Nanoparticles. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Xiamen, Program for Innovative Research Team in Science and Technology in Fujian Province University and the Scientific Research Funds of Huaqiao University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug resistance (MDR) in cancer is driven by hypoxia, elevated antioxidant capacity, and drug efflux. Herein, a universal MDR‐reversal nanoplatform based on hyaluronic acid (HA)‐templated manganese oxide nanosheets (MH NSs) was developed through a biomineralization strategy. The coexistence of Mn(II)/Mn(III)/Mn(IV) endows MH NSs with coordinated multienzyme‐like reactivity, including peroxidase (POD)‐like ROS amplification, glutathione oxidase (GSHOx)‐like redox disruption, and catalase (CAT)‐like hypoxia relief, which collectively remodel the tumor microenvironment and dismantle MDR defenses. The platform exhibits broad drug‐loading compatibility through multiple interactions, including electrostatic binding, metal‐ligand coordination, and hydrophobic encapsulation. Using doxorubicin (DOX) as a model drug, DOX‐loaded MH NSs (MH‐DOX) achieve CD44‐targeted delivery, clathrin‐mediated endocytosis, and evasion of efflux clearance. Mechanistically, the CAT‐like activity of MH NSs relieves hypoxia and suppresses the HIF‐1α/MDR1/P‐gp axis, the POD‐like catalysis enhances ROS accumulation to activate the apoptotic cascade, and the GSHOx‐like function depletes intracellular GSH and inhibits GPX4 to induce ferroptosis. Notably, MH NSs supports DOX intersystem crossing, enabling ultrasound‐triggered production of 1 O 2 and ·OH. Acting in concert with the redox cascades, MH‐DOX synergistically overcomes MDR barriers, enabling dual apoptosis‐ferroptosis induction and significantly enhancing DOX sensitivity. Collectively, MH NSs represent a programmable nanozyme platform broadly applicable to redox‐regulated drug delivery and resistance modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmDrug Resistance, MultipleNanoparticlesDoxorubicinAnimalsOxidation-ReductionHumansOxidesBiomineralizationCell Line, TumorManganese CompoundsHyaluronic AcidReactive Oxygen SpeciesTumor MicroenvironmentCatalaseMice

Stichwörter der Autor:innen

biomineralizationmultidrug resistancemultienzyme‐like reactivitynanozymetumor microenvironment remodeling

Substanzen

DoxorubicinOxidesManganese Compoundsmanganese oxideHyaluronic AcidReactive Oxygen SpeciesCatalase

Autor:innen und Institutionen

  • Fujian Provincial Key Laboratory of Biochemical Technology & Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen, China.
  • Center for Nanomedicine and Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • College of Medicine, Huaqiao University, Quanzhou, China.

ORCID-Profile: Da-Gui Zhang, Yang Zhang, Wei-Guang Xiong, Ai-Zheng Chen, Biao-Qi Chen

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Xiamen
  • Program for Innovative Research Team in Science and Technology in Fujian Province University and the Scientific Research Funds of Huaqiao University
  • Science and Technology Projects in Fujian Province : 2023Y4008 : 2022FX1
  • Natural Science Foundation of Fujian Province : 2024J01092

Zitieren

APA

Zhang, D. G., Zhang, Y., Hong, H. Y., Lu, X. C., Xiong, W. G., Qiu, Y. T., Xu, Q. X., Wang, Z. T., Chen, L. F., Chen, A. Z., Wang, S. B., & Chen, B. Q. (2026). Biomineralized Multienzyme‐Mimicking 2D Nanoplatform Achieves Efficient Redox‐Governed Reversal of Tumor Multidrug Resistance. Advanced Healthcare Materials, 15(42). https://doi.org/10.1002/adhm.71617

Vancouver

Zhang DG, Zhang Y, Hong HY, Lu XC, Xiong WG, Qiu YT, et al. Biomineralized Multienzyme‐Mimicking 2D Nanoplatform Achieves Efficient Redox‐Governed Reversal of Tumor Multidrug Resistance. Advanced Healthcare Materials. 2026;15(42). doi:10.1002/adhm.71617

BibTeX
@article{Zhang2026,
  author = {Zhang, Da-Gui and Zhang, Yang and Hong, Hui-Ya and Lu, Xiao-Chang and Xiong, Wei-Guang and Qiu, Yi-Ting and Xu, Qin-Xi and Wang, Ze-Teng and Chen, Lin-Fei and Chen, Ai-Zheng and Wang, Shi-Bin and Chen, Biao-Qi},
  title = {Biomineralized Multienzyme‐Mimicking 2D Nanoplatform Achieves Efficient Redox‐Governed Reversal of Tumor Multidrug Resistance},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {42},
  doi = {10.1002/adhm.71617}
}
Kostenlos starten →